Eye Care Webinar
Enhance Your Daily Patient
Management with
Wide Field OCT
Eye Care Webinar
Enhance Your Daily Patient
Management with
Wide Field OCT
Eye Care Webinar
Enhance Your Daily Patient
Management with
Wide Field OCT
Eye Care Webinar
Enhance Your Daily Patient
Management with
Wide Field OCT
Enhance Your Daily Patient
Management with
Wide Field OCT
Eye Care Live Webinar | June 14, 2022, 7 pm (CEST) / 1 pm (EDT)
Enhance Your Daily Patient Management with Wide Field OCT
In this webinar, we will take a closer look at specific pathologies and how OCT and OCTA can help you in your patient management. We will go more in depth into peripheral pathologies and pachychoroid diseases. Also, we will discuss the long-term effects in the evolution of retinal and microvascular alterations in patients with Long COVID.
This webinar occurs now in the past. The recording is available.
This webinar occurs now in the past. The recording is available.
Please accept marketing-cookies to watch this video.
Program
Why should you attend ?
- OCT-A as a window to COVID-19 - the potential – Prof. Tariq Aslam & Dr. Orlaith McGrath
- Overview of choroidal diseases using the wide field OCT-S1 Xephilio and focus on the pachychoroid disease spectrum. - Dr. Prithvi Ramtohul
- Objective Assessment of Posterior Vitreous Detachment (PVD) Status and the Peripheral Vitreoretinal Interface & Retina: New 3D 23 mm Wide Field OCT.- Prof. Paulo E. Stanga
- Live Q&A
Why should you attend ?
- Use of OCTA to analyze the effect of COVID-19 on the retinal microvasculature
- Assess the Vitreoretinal Interface (VRI) to establish the Status of Posterior Vitreous Detachment (PVD)
- Wide field choroidal thickness map may be an additional parameter to evaluate therapeutic interventions in patients with pachychoroid diseases.
EXTENSIVE INFORMATION ON SPEAKERS AND PRESENTATIONS
Speaker: Prof. Tariq Aslam, MD, PhD MA (Oxon), DM (Oxon), FRCSEd (Ophth),
Consultant Ophthalmologist
Manchester Royal Eye Hospital
Manchester, UK
Prof. Tariq Aslam began his medical training at Oxford University and completed his medical retina fellowship at Moorfields Eye Hospital. His first research doctorate from Oxford University involved clinical trials in ophthalmic surgery and a further PhD from Heriot-Watt University investigated technology applications in ophthalmology. Both doctorate theses utilized his skills in computer programming and his most recent led to a prize for the best PhD across all University disciplines. His current research explores many clinical interests in the retina including psychological aspects and the potential for computerized and technological enhancement of patient care including novel device development. He has over 100 peer-reviewed publications, predominantly as lead author, a number of patents and is an investigator on multiple commercial as well as investigator lead studies. His research has led to a spin-out medical technology company with awards for social impact, which is his ultimate research goal.
Presentation title: OCT-A as a Window to COVID-19 - the Potential – Part I
Consultant Ophthalmologist
Manchester Royal Eye Hospital
Manchester, UK
Prof. Tariq Aslam began his medical training at Oxford University and completed his medical retina fellowship at Moorfields Eye Hospital. His first research doctorate from Oxford University involved clinical trials in ophthalmic surgery and a further PhD from Heriot-Watt University investigated technology applications in ophthalmology. Both doctorate theses utilized his skills in computer programming and his most recent led to a prize for the best PhD across all University disciplines. His current research explores many clinical interests in the retina including psychological aspects and the potential for computerized and technological enhancement of patient care including novel device development. He has over 100 peer-reviewed publications, predominantly as lead author, a number of patents and is an investigator on multiple commercial as well as investigator lead studies. His research has led to a spin-out medical technology company with awards for social impact, which is his ultimate research goal.
Presentation title: OCT-A as a Window to COVID-19 - the Potential – Part I
Speaker: Dr. Orlaith McGrath, MB, BCh, BAO
Ophthalmology Clinical Research Fellow
University of Manchester
Manchester, United Kingdom
Dr. Orlaith McGrath is an Ophthalmology Clinical Research Fellow working with Professor Tariq Aslam at the Manchester Royal Eye Hospital. Orlaith is carrying out an MPhil in Ophthalmology Technical Applications with the University of Manchester. She worked as an Ophthalmology Senior House Officer in Cork University Hospital, Ireland last year and she is currently in the process of applying for Ophthalmology national recruitment here in the UK.
Presentation title: OCT-A as a Window to COVID-19 - the Potential – Part II
Multiple studies have found retinal changes in the acute phase of COVID-19. This study was carried out to evaluate the long-term evolution of retinal and microvascular alterations in patients post- COVID-19. Patients diagnosed with long COVID and patients post-hospitalization for COVID pneumonitis were compared with a control cohort. Patients were imaged 6-24 months post-infection.
Ophthalmology Clinical Research Fellow
University of Manchester
Manchester, United Kingdom
Dr. Orlaith McGrath is an Ophthalmology Clinical Research Fellow working with Professor Tariq Aslam at the Manchester Royal Eye Hospital. Orlaith is carrying out an MPhil in Ophthalmology Technical Applications with the University of Manchester. She worked as an Ophthalmology Senior House Officer in Cork University Hospital, Ireland last year and she is currently in the process of applying for Ophthalmology national recruitment here in the UK.
Presentation title: OCT-A as a Window to COVID-19 - the Potential – Part II
Multiple studies have found retinal changes in the acute phase of COVID-19. This study was carried out to evaluate the long-term evolution of retinal and microvascular alterations in patients post- COVID-19. Patients diagnosed with long COVID and patients post-hospitalization for COVID pneumonitis were compared with a control cohort. Patients were imaged 6-24 months post-infection.
Speaker: Dr. Prithvi Ramtohul, MD
Retinal specialist
Research fellow at the Vitreous Retina Macula Consultants of New York
Vitreous Retina Macula Consultants of New York
New York, USA.
Dr. Prithvi Ramtohul has completed his medical school in Marseille, France. He is doing his research fellowship at the Vitreous Retina Macula Consultants of New York, under the supervision of a faculty mentor, Professor K. Bailey Freund. He has published more than 50 peer-reviewed articles in international journals and written several book chapters.
Presentation title: Overview Of Choroidal Diseases Using the Wide field OCT-S1 Xephilio and Focus on the Pachychoroid Disease Spectrum.
To correlate patterns of choroidal venous drainage in eyes with pachychoroid diseases using ultra wide field indocyanine green angiography (UWF ICGA) and en face wide field optical coherence tomography (WF-OCT) imaging.
Retinal specialist
Research fellow at the Vitreous Retina Macula Consultants of New York
Vitreous Retina Macula Consultants of New York
New York, USA.
Dr. Prithvi Ramtohul has completed his medical school in Marseille, France. He is doing his research fellowship at the Vitreous Retina Macula Consultants of New York, under the supervision of a faculty mentor, Professor K. Bailey Freund. He has published more than 50 peer-reviewed articles in international journals and written several book chapters.
Presentation title: Overview Of Choroidal Diseases Using the Wide field OCT-S1 Xephilio and Focus on the Pachychoroid Disease Spectrum.
To correlate patterns of choroidal venous drainage in eyes with pachychoroid diseases using ultra wide field indocyanine green angiography (UWF ICGA) and en face wide field optical coherence tomography (WF-OCT) imaging.
Moderator & Speaker: Prof. Paulo E. Stanga, MD
Ophthalmologist, Vitreoretinal Surgeon
Head of the Retina Clinic London
London, UK
Prof. Stanga specializes in Medical & Surgical Retina, Macular Degeneration, Diabetic Retinopathy, Vitreous Floaters, Cataracts, Retinal Laser, R&D New Therapies, Surgical Technology, Advanced Imaging & Clinical Studies, with over 32 years of experience in Ophthalmology.
Presentation title: Objective Assessment of Posterior Vitreous Detachment (PVD) Status and the Peripheral Vitreoretinal Interface & Retina: New 3D 23 mm Wide Field OCT.
Assess the Vitreoretinal Interface (VRI) to establish the Status of Posterior Vitreous Detachment (PVD) and Objectively Diagnose the Absence or Presence of a Partial or Full PVD and Quantify it, as well as assess the Peripheral Retina using Single Scan Cross-Sectional and 3D 23 mm Wide field Swept- Source OCT (SS WF-OCT).
Ophthalmologist, Vitreoretinal Surgeon
Head of the Retina Clinic London
London, UK
Prof. Stanga specializes in Medical & Surgical Retina, Macular Degeneration, Diabetic Retinopathy, Vitreous Floaters, Cataracts, Retinal Laser, R&D New Therapies, Surgical Technology, Advanced Imaging & Clinical Studies, with over 32 years of experience in Ophthalmology.
Presentation title: Objective Assessment of Posterior Vitreous Detachment (PVD) Status and the Peripheral Vitreoretinal Interface & Retina: New 3D 23 mm Wide Field OCT.
Assess the Vitreoretinal Interface (VRI) to establish the Status of Posterior Vitreous Detachment (PVD) and Objectively Diagnose the Absence or Presence of a Partial or Full PVD and Quantify it, as well as assess the Peripheral Retina using Single Scan Cross-Sectional and 3D 23 mm Wide field Swept- Source OCT (SS WF-OCT).
Other webinars that may interest you
Eye Care Webinars Ophthalmology Webinars
Disclaimers
Due to medical device regulatory reasons, not all products/services displayed on this Canon Medical Systems webpage are available in all countries or markets. Future availability of the products/service cannot also be guaranteed. Don't hesitate to contact your local Canon Medical Systems representative for further details.
